| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | 6.2× | −1.7× | |
| Price / Book | 0.6× | 2.0× | |
| Price / Sales | 0.4× | 4.0× | |
| Price / Free cash flow | 2.1× | −1.6× | |
| EV / EBITDA | 2.9× | −1.2× | |
| Earnings yield | 16.1% | −14.6% | |
| Free cash flow yield | 47.9% | −9.9% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,250.44 | −0.52% | $1.18T | 57.3× | 77.8% | +16.7% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $254.43 | −0.44% | $613.15B | 23.0× | 32.9% | +33.7% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $284.29 | −0.40% | $502.37B | 119.3× | −129.2% | +26.2% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $405.44 | +1.00% | $363.92B | 29.9× | 12.8% | +11.2% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $144.24 | −1.17% | $355.86B | 19.7× | 34.7% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $150.52 | −0.07% | $278.45B | 19.8× | 30.5% | +15.9% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $164.64 | −0.47% | $255.33B | 25.0× | 21.1% | −2.2% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $680.66 | −1.35% | $251.67B | 37.9× | 12.6% | +30.7% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $428.40 | −0.95% | $231.6B | 30.3× | 89.1% | +45.5% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $154.38 | −1.16% | $191.42B | 22.8× | 37.5% | +32.0% |
